Ursodeoxycholic acid switches oxaliplati
β
Sung-Chul Lim; Jeong Eun Choi; Ho Sung Kang; Han SI
π
Article
π
2009
π
John Wiley and Sons
π
French
β 641 KB
## Abstract Hepatocellular carcinoma (HCC) is resistant to chemotherapy. Recently, however, several oxaliplatinβbased combinatorial treatments have shown a promising antiβtumor activity in patients with HCC. Presently, we demonstrate that oxaliplatin triggers necrosis more than apoptosis in HepG2,